Hereditary Cancer Panel

Standard tumor marker tests (CEA, PSA, CA-125, etc.) only detect biochemical signals — which are often elevated only when cancer is already present or advanced. The Hereditary Cancer Panel adds genetic risk assessment — analyzing 700,000+ inherited DNA variants across 100+ cancer genes. This identifies genetic predisposition years or decades before cancer develops, enabling truly preventive action rather than reactive detection.

Cancer risk assessment involves complex genetic and biochemical findings that require clinical context to interpret and act upon. A doctor's referral ensures the test is ordered appropriately and that results — particularly any high-risk findings — are reviewed in the context of your personal and family medical history. Our Genomic Expert will also provide post-result consultation to help translate findings into actionable steps.

Finding elevated genetic risk does not mean you have cancer — it means you have increased inherited susceptibility that warrants proactive management. Our Genomic Expert will review high-risk findings with you in detail and recommend a personalized action plan, which may include more frequent cancer-specific screening (colonoscopy, mammography, PSA monitoring, etc.), specialist referral, lifestyle interventions, or in certain cases, prophylactic options. Early knowledge is powerful — most hereditary cancers are highly treatable when detected early.

Yes. All data is protected under ISO 27001, HIPAA, and GDPR standards. Your genetic and health information is never shared with insurance companies, employers, or any third party without your explicit consent. You retain full ownership and control of your information at all times.